Mahsa Toolabi

449 total citations
24 papers, 351 citations indexed

About

Mahsa Toolabi is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Mahsa Toolabi has authored 24 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Mahsa Toolabi's work include Synthesis and biological activity (14 papers), Click Chemistry and Applications (7 papers) and Quinazolinone synthesis and applications (7 papers). Mahsa Toolabi is often cited by papers focused on Synthesis and biological activity (14 papers), Click Chemistry and Applications (7 papers) and Quinazolinone synthesis and applications (7 papers). Mahsa Toolabi collaborates with scholars based in Iran, Cyprus and Türkiye. Mahsa Toolabi's co-authors include Alireza Foroumadi, Setareh Moghimi, Adileh Ayati, Loghman Firoozpour, Somayeh Salarinejad, Rezvan Esmaeili, Fatemeh Safari, Mohammad Ali Faramarzi, Somayeh Mojtabavi and Seyed Esmaeil Sadat Ebrahimi and has published in prestigious journals such as International Journal of Biological Macromolecules, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Mahsa Toolabi

23 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mahsa Toolabi Iran	11	261	131	45	39	31	24	351
Perwaiz Alam India	6	319 1.2×	109 0.8×	39 0.9×	46 1.2×	29 0.9×	7	423
Ola I. A. Salem Egypt	14	418 1.6×	217 1.7×	58 1.3×	76 1.9×	62 2.0×	26	586
Mohd Adil Shareef India	14	398 1.5×	165 1.3×	44 1.0×	47 1.2×	40 1.3×	25	549
Zarina Shulgau Kazakhstan	11	208 0.8×	98 0.7×	19 0.4×	19 0.5×	22 0.7×	57	355
Yasmin M. Syam Egypt	13	383 1.5×	184 1.4×	83 1.8×	80 2.1×	84 2.7×	25	527
Bharath Kumar Chagaleti India	10	131 0.5×	97 0.7×	82 1.8×	36 0.9×	16 0.5×	29	273
Manoj Kumar Mahapatra India	10	171 0.7×	144 1.1×	98 2.2×	33 0.8×	37 1.2×	16	368
Mandava Bhuvan Tej India	9	151 0.6×	115 0.9×	28 0.6×	40 1.0×	13 0.4×	18	303
Ahmed M. Said Egypt	10	178 0.7×	122 0.9×	43 1.0×	82 2.1×	25 0.8×	27	350
Anber F. Mohammed Egypt	11	203 0.8×	129 1.0×	37 0.8×	53 1.4×	26 0.8×	27	320

Countries citing papers authored by Mahsa Toolabi

Since Specialization

Citations

This map shows the geographic impact of Mahsa Toolabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahsa Toolabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahsa Toolabi more than expected).

Fields of papers citing papers by Mahsa Toolabi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahsa Toolabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahsa Toolabi. The network helps show where Mahsa Toolabi may publish in the future.

Co-authorship network of co-authors of Mahsa Toolabi

This figure shows the co-authorship network connecting the top 25 collaborators of Mahsa Toolabi. A scholar is included among the top collaborators of Mahsa Toolabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahsa Toolabi. Mahsa Toolabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toolabi, Mahsa, et al.. (2025). Coumarin derivatives as potential anticancer agents: Synthesis, antiproliferative activity, apoptosis, and molecular docking studies. Results in Chemistry. 16. 102442–102442. 1 indexed citations

Toolabi, Mahsa, et al.. (2025). Chitosan-coated liposomes for sustained levetiracetam delivery: In-silico and in-vitro evaluation. International Journal of Biological Macromolecules. 328(Pt 2). 147682–147682.

Salarinejad, Somayeh, Setareh Moghimi, Mahsa Toolabi, et al.. (2024). Design, synthesis, and biological evaluation of new biaryl derivatives of cycloalkyl diacetamide bearing chalcone moiety as type II c-MET kinase inhibitors. Molecular Diversity. 28(6). 4167–4180. 1 indexed citations

Ebadi, Ahmad, et al.. (2024). Synthesis of Novel 3,4‐Dihydropyrimidine Derivatives, Cytotoxic Activity Evaluation, Apoptosis, Molecular Docking Studies, and MD Simulations. Chemistry & Biodiversity. 22(1). e202402170–e202402170. 3 indexed citations

Salarinejad, Somayeh, Setareh Moghimi, Mahsa Toolabi, et al.. (2024). Synthesis, biological activities, and molecular docking studies of triazolo[4,3‐b]triazine derivatives as a novel class of α‐glucosidase and α‐amylase inhibitors. Archiv der Pharmazie. 357(7). e2300628–e2300628. 9 indexed citations

Peytam, Fariba, Loghman Firoozpour, Setareh Moghimi, et al.. (2023). Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies. Bioorganic Chemistry. 133. 106383–106383. 10 indexed citations

Firoozpour, Loghman, et al.. (2023). Design, synthesis and α-glucosidase inhibition study of novel pyridazin-based derivatives. Medicinal Chemistry Research. 32(4). 713–722. 7 indexed citations

Firoozpour, Loghman, Setareh Moghimi, Somayeh Salarinejad, et al.. (2023). Synthesis, α-Glucosidase inhibitory activity and docking studies of Novel Ethyl 1,2,3-triazol-4-ylmethylthio-5,6-diphenylpyridazine-4-carboxylate derivatives. BMC Chemistry. 17(1). 66–66. 4 indexed citations

Toolabi, Mahsa, et al.. (2023). Development and Validation of an Analytical RP-HPLC Method for Simultaneous Estimation of Losartan and its Active Metabolite (EXP-3174) in Isolated Perfused Rat Liver. Current Pharmaceutical Analysis. 19(10). 786–793. 1 indexed citations

10.

Ayati, Adileh, Setareh Moghimi, Mahsa Toolabi, & Alireza Foroumadi. (2021). Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy. European Journal of Medicinal Chemistry. 221. 113523–113523. 83 indexed citations

11.

Moghimi, Setareh, Somayeh Salarinejad, Mahsa Toolabi, et al.. (2021). Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors. Bioorganic Chemistry. 109. 104670–104670. 33 indexed citations

12.

Toolabi, Mahsa, Mona Khoramjouy, Adileh Ayati, et al.. (2020). Synthesis and radioligand‐binding assay of 2,5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities. Archiv der Pharmazie. 353(12). e2000066–e2000066. 12 indexed citations

13.

Moghimi, Setareh, Mahsa Toolabi, Somayeh Salarinejad, et al.. (2020). Design and synthesis of novel pyridazine N-aryl acetamides: In-vitro evaluation of α-glucosidase inhibition, docking, and kinetic studies. Bioorganic Chemistry. 102(262). 104071–104071. 21 indexed citations

14.

Navidpour, Latifeh, Alireza Heidari, Azadeh Ebrahim‐Habibi, et al.. (2020). 5-[Aryloxypyridyl (or nitrophenyl)]-4H-1,2,4-triazoles as novel flexible benzodiazepine analogues: Synthesis, receptor binding affinity and lipophilicity-dependent anti-seizure onset of action. Bioorganic Chemistry. 106. 104504–104504. 11 indexed citations

15.

Salarinejad, Somayeh, et al.. (2020). Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety. DARU Journal of Pharmaceutical Sciences. 28(2). 661–672. 20 indexed citations

16.

Toolabi, Mahsa, Setareh Moghimi, Loghman Firoozpour, et al.. (2020). Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity. Bioorganic Chemistry. 108. 104553–104553. 27 indexed citations

17.

Toolabi, Mahsa, et al.. (2019). 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action. Bioorganic & Medicinal Chemistry. 27(16). 3682–3691. 13 indexed citations

18.

Toolabi, Mahsa, Setareh Moghimi, Somayeh Salarinejad, et al.. (2019). 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies. European Journal of Medicinal Chemistry. 185. 111786–111786. 39 indexed citations

19.

Toolabi, Mahsa, Setareh Moghimi, Hamid Nadri, et al.. (2019). Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors. Molecular Diversity. 24(4). 997–1013. 18 indexed citations

20.

Toolabi, Mahsa, Pariya Khodabakhsh, Hamed Shafaroodi, et al.. (2016). Synthesis, conformational assignment, and anti-inflammatory activities of N-arylidene-2-(4-chloro-2-(2-substituted phenoxy)phenyl)acetic acid hydrazides. Medicinal Chemistry Research. 25(10). 2220–2236. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact